Skip to main content
. 2018 Jul 10;16(3):3992–4000. doi: 10.3892/ol.2018.9113

Figure 3.

Figure 3.

Comparison of the fraction of tumor-infiltrating immune cell types in LUAD and LUSC using nuclear gene mRNA expression profiles. Box plots presenting the evaluated fractions of immune cell types (y-axis) are plotted by cancer subtype (x-axis). (A) Comparison of the evaluated fraction of CD4+ T cells and macrophages between LUAD and LUSC. (B) Comparison of the evaluated fraction of CD4+ T cells across the three lung cancer subtypes. (C) Comparison of the evaluated fraction of B cells across the three lung cancer subtypes. LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma.